{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:30:38Z","timestamp":1770841838047,"version":"3.50.1"},"reference-count":31,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2022,3,31]]},"DOI":"10.7883\/yoken.jjid.2021.450","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T22:11:27Z","timestamp":1632953487000},"page":"177-182","source":"Crossref","is-referenced-by-count":6,"title":["The Use of Topical Antibiotics Based on the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) Open Data in 2017"],"prefix":"10.7883","volume":"75","author":[{"given":"Tomoko","family":"Nakanishi","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacoepidemiology, Kyoto Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Inose","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacoepidemiology, Kyoto Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Kusama","sequence":"additional","affiliation":[{"name":"AMR Clinical Reference Center, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ishikane","sequence":"additional","affiliation":[{"name":"AMR Clinical Reference Center, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Kajihara","sequence":"additional","affiliation":[{"name":"Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Yahara","sequence":"additional","affiliation":[{"name":"Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoyuki","family":"Sugai","sequence":"additional","affiliation":[{"name":"Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Ohge","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hiroshima University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Ohmagari","sequence":"additional","affiliation":[{"name":"AMR Clinical Reference Center, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Muraki","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacoepidemiology, Kyoto Pharmaceutical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Yamasaki D, Tanabe M, Muraki Y, et al. The first report of Japanese antimicrobial use measured by national database based on health insurance claims data (2011\u20132013): comparison with sales data, and trend analysis stratified by antimicrobial category and age group. Infection. 2018;46:207-214.","DOI":"10.1007\/s15010-017-1097-x"},{"key":"2","unstructured":"2. World Health Organization (WHO). Antimicrobial resistance global report on surveillance. Geneva: WHO; 2014."},{"key":"3","unstructured":"3. The Government of Japan. National Action Plan on Antimicrobial Resistance (AMR) 2016-2020. Available at &lt;https:\/\/www.mhlw.go.jp\/file\/06-Seisakujouhou-10900000-Kenkoukyoku\/0000138942.pdf&gt;. Accessed February 9, 2021."},{"key":"4","unstructured":"4. National Center for Global Health and Medicine. AMR One Health Trend Survey 2019 report. Available at &lt;https:\/\/amr-onehealth.ncgm.go.jp\/&gt;. Accessed February 9, 2021. Japanese."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Bremond-Gignac D, Chiambaretta F, Milazzo S. A European perspective on topical ophthalmic antibiotics; current and evolving options. Ophthalmol Eye Dis. 2011;3:29-43.","DOI":"10.4137\/OED.S4866"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Zabielinski M, McLeod MP, Aber C, et al. Trends and antibiotic susceptibility patterns of methicillin-resistant and methicillin-sensitive <i>Staphylococcus aureus<\/i> in an outpatient dermatology facility. JAMA Dermatol. 2013;149:427-432.","DOI":"10.1001\/jamadermatol.2013.2424"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Mita Y, Inose R, Goto R, et al. An alternative index for evaluating AMU and anti-methicillin-resistant <i>Staphylococcus aureus<\/i> agent use: A study based on the National Database of Health Insurance Claims and Specific Health Checkups data of Japan. J Infect Chemother. 2021;27:972-976.","DOI":"10.1016\/j.jiac.2021.02.009"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Goto R, Inose R, Kusama Y, et al. Trends of the use of anti-methicillin-resistant <i>Staphylococcus aureus<\/i> agents in Japan based on sales data from 2006 to 2015. Biol Pharm Bull. 2020;43:1906-1910.","DOI":"10.1248\/bpb.b20-00605"},{"key":"9","unstructured":"9. Ministry of Health, Labour and Welfare. The 4th NDB Open Data Commentary. Available at &lt;https:\/\/www.mhlw.go.jp\/content\/12400000\/000711802.pdf&gt;. Accessed October 10, 2020. Japanese. Abstract in English."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Mukai R, Shimada K, Suzuki T, et al. Trends associated with hemorrhoids in Japan: Data mining of medical information datasets and the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) Open Data Japan. Biol Pharm Bull. 2020;43:1831-1838.","DOI":"10.1248\/bpb.b20-00157"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Katano H, Ozeki N, Kohno Y, et al. Trends in arthroplasty in Japan by a complete survey, 2014\u20132017. J Orthop Sci. 2021;26:812-822.","DOI":"10.1016\/j.jos.2020.07.022"},{"key":"12","unstructured":"12. Ministry of Health, Labour and Welfare. The 4th NDB Open Data. Available at &lt;https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000177221_00003.html&gt;. Accessed October 10, 2020. Japanese."},{"key":"13","unstructured":"13. WHO Collaborating Centre for Drug Statistics Methodology. ATC\/DDD index 2020. Available at &lt;https:\/\/www.whocc.no\/atc_ddd_index\/&gt;. Accessed December 4, 2020."},{"key":"14","unstructured":"14. Ministry of Health, Labour and Welfare. List of items listed in the NHI Drug Price Standard. Available at &lt;https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000078916.html&gt;. Accessed October 10, 2020. Japanese."},{"key":"15","unstructured":"15. Medical Information System Development Center (MEDIS-DC). Available at &lt;https:\/\/www.medis.or.jp\/4_hyojyun\/medis-master\/&gt;. Accessed October 10, 2020. Japanese."},{"key":"16","unstructured":"16. Statistics Bureau of Japan. Population Estimates. Available at &lt;https:\/\/www.e-stat.go.jp\/dbview?sid=0003215842&gt;. Accessed December 15, 2020. Japanese."},{"key":"17","unstructured":"17. Japanese Society of Chemotherapy\/Japan Society for Surgical Infection. Practical guidelines for proper use of antibacterial agents to prevent postoperative infection (supplementary version). Jpn J Chemotherapy. 2020;68:310-320. Available at &lt;http:\/\/www.chemotherapy.or.jp\/guideline\/jyutsugo_shiyou_tuiho.pdf&gt;. Accessed December 15, 2020. Japanese."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Furue M, Yamazaki S, Jimbow K, et al. Prevalence of dermatological disorders in Japan: a nationwide, cross-sectional, seasonal, multicenter, hospital-based study. J Dermatol. 2011;38:310-320.","DOI":"10.1111\/j.1346-8138.2011.01209.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hayashi N, Akamathu H, Iwatsuki K, et al. Japanese Dermatological Association Guidelines: Guidelines for the treatment of acne vulgaris 2017. J Dermatol. 2018;45:898-935.","DOI":"10.1111\/1346-8138.14355"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Nakase K, Aoki S, Sei S, et al. Characterization of acne patients carrying clindamycin-resistant <i>Cutibacterium acnes<\/i>: A Japanese multicenter study. J Dermatol. 2020;47:863-869.","DOI":"10.1111\/1346-8138.15397"},{"key":"21","unstructured":"21. The Japanese Association for Infectious Diseases (JAID) and Japan Society of Chemotherapy (JSC), Guideline committee for clinical management of infectious diseases. Contagious impetigo. The JAID \/ JSC Guide to Clinical Management of Infectious Diseases 2019. Tokyo, Japan: JAID \/ JSC; 2019. p.185. Japanese."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Bowen AC, Mah\u00e9 A, Hay RJ, et al. The global epidemiology of impetigo: A systematic review of the population prevalence of impetigo and pyoderma. PLoS One. 2015;10:e0136789.","DOI":"10.1371\/journal.pone.0136789"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Williamson DA, Moneche S, Heffernan H, et al. High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant <i>Staphylococcus aureus<\/i>: A cautionary tale. Clin Infect Dis. 2014;59:1451-1454.","DOI":"10.1093\/cid\/ciu658"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Carter GP, Schultz MB, Baines SL, et al. Topical antibiotic use coselects for the carriage of mobile genetic elements conferring resistance to unrelated antimicrobials in <i>Staphylococcus aureus<\/i>. Antimicrob Agents Chemother. 2018;62:e02000-17.","DOI":"10.1128\/AAC.02000-17"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Deguchi H, Kitazawa K, Kayukawa K, et al. The trend of resistance to antibiotics for ocular infection of <i>Staphylococcus aureus<\/i>, coagulase-negative staphylococci, and <i>Corynebacterium<\/i> compared with 10-years previous: A retrospective observational study. PLoS One. 2018;13:e0203705.","DOI":"10.1371\/journal.pone.0203705"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. H\u00f8vding G. Acute bacterial conjunctivitis. Acta Ophthalmol. 2008;86:5-17.","DOI":"10.1111\/j.1600-0420.2007.01006.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Guirguis-Blake JM, Evans CV, Rushkin M. Ocular prophylaxis for gonococcal ophthalmia neonatorum: Updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2019;321:404-406.","DOI":"10.1001\/jama.2018.17847"},{"key":"28","unstructured":"28. Arakaki Y, Hayakawa K, Mori F, et al. Perioperative antibiotics effectiveness on conjunctival flora and microbial sensitivity. Nippon Ganka Gakkai Zasshi. 2009;113:906-912. Japanese."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Joussen AM, Funke G, Joussen F, et al. <i>Corynebacterium macginleyi<\/i>: a conjunctiva specific pathogen. Br J Ophthalmol. 2000;84:1420-1422.","DOI":"10.1136\/bjo.84.12.1420"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Eguchi H, Kuwahara T, Miyamoto T, et al. High-level fluoroquinolone resistance in ophthalmic clinical isolates belonging to the species <i>Corynebacterium macginleyi<\/i>. J Clin Microbiol. 2008;46:527-532.","DOI":"10.1128\/JCM.01741-07"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Funke G, Pagano-Niederer M, Bernauer W. <i>Corynebacterium macginleyi<\/i> has to date been isolated exclusively from conjunctival swabs. J Clin Microbiol. 1998;36:3670-3673.","DOI":"10.1128\/JCM.36.12.3670-3673.1998"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/75\/2\/75_JJID.2021.450\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T04:42:00Z","timestamp":1648269720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/75\/2\/75_JJID.2021.450\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,31]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2021.450","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,31]]},"article-number":"JJID.2021.450"}}